AYTU
$2.65
Aytu Biopharma
($.02)
(.75%)
AYTU
Earnings Whisper ®
N/A
1st Quarter September 2021
Consensus:  ($0.08)
Revenue:  $23.25 Mil
Monday
Dec 27
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when AYTU reports earnings?
Beat
Meet
Miss

Where is AYTU's stock price going from here?
Up
Flat
Down
Stock chart of AYTU
Analysts
Summary of analysts' recommendations for AYTU
Score
Grade
Pivots
Resistance
$2.81
$2.76
$2.71

$2.66

Support
$2.61
$2.56
$2.51
Tweet
Growth
Description
Aytu BioScience, Inc. is a healthcare company which focused on commercialization of novel products in the field of urology. The company's marketed products consists of ProstaScint(R), Primsol(R) and MiOXSYS(TM) which addresses prostate cancer, urinary tract infections, male infertility and male sexual dysfunction. Aytu BioScience, Inc. is based in Englewood, Colorado.